RANBAXY Laboratories is voluntarily recalling a batch of its best-selling anti-acne drug remaining in the US market that was banned earlier by the American regulator after it failed a dissolution test to assess the efficacy, uniformity and stability of the dosage.
The product figured among the 30 Ranbaxy drugs banned by the US Food and Drug Administration (USFDA) in September 2007, but the regulator had allowed the company to sell those drugs that were already in the market after it was not found to be unsafe.
Every time an offender stealthily leaves India to take refuge in another country, the Government of India starts all over again with its strategy of bringing him back to the nation to make him stan More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More